The FDA has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints

Quick Read

Dr. Richard Valery Mouzoko Kiboung arrived in Democratic Republic of the Congo just four weeks ago – one of hundreds of disease experts that the World Health Organization has recruited to help curb the ongoing Ebola outbreak there

Quick Read

Across the U.S., many doctors, nurses and other health care workers have remained silent about what is being called an epidemic of violence against them. The violent outbursts come from patients and patients’ families. And for years, it’s been considered part of the job

Quick Read

“Tonight another deplorable attack on an Ebola treatment facility has taken place, this time in the city of Butembo,” said Hugues Robert, MSF emergency desk manager, in a news release

Quick Read

Mary Politi writes, “Weeks after my father passed away from cancer in 2010, my newly widowed mother received a bill for US $11,000.”

Quick Read

The claim was that larger organizations would be able to harness economies of scale and offer better care

Quick Read

The health system is boosting its investment in Epicured, which provides meals for patients with digestive diseases. “Transparency has to be meaningful, honest, consistent and understandable,” said Dr. Ruth Faden, founder of the Johns Hopkins Berman Institute of Bioethics in Baltimore

Quick Read

The FDA said that it had also written to 20 clinics that offer unapproved stem cell treatments, warning them that such products are generally regulated by the agency and encouraging the clinics to contact federal regulators before November 2020, when enforcement will tighten

Quick Read